Seeing Is Believing
Healthcare - Sector
NRIX is currently covered by 12 analysts with an average price target of $31.57. This is a potential upside of $12.31 (23.66%) from yesterday's end of day stock price of $25.53.
Nurix Therapeutics 's activity chart (see below) currently has 180 price targets and 178 ratings on display. The stock rating distribution of NRIX is 94.34% BUY and 5.66% HOLD.
Analysts average stock forecasts to be materialized ratio is 33.45% with an average time for these price targets to be met of 142.67 days.
Highest price target for NRIX is $40, Lowest price target is $23, average price target is $31.57.
Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 28-Jul-2026. First documented stock forecast 18-Aug-2020.
Currently out of the existing stock ratings of NRIX, 50 are a BUY (94.34%), 3 are a HOLD (5.66%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2026
$38
$14.79 (63.72%)
$36
Buy Since 10-Apr-2025
$31
$7.79 (33.56%)
$30
Buy Since 27-Oct-2021
$34
$10.79 (46.49%)
$35
Buy Since 18-Aug-2020
$40
$16.79 (72.34%)
$35
Buy Since 13-Jun-2025
$33
$9.79 (42.18%)
$30
What is NRIX (Nurix Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on NRIX (Nurix Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on NRIX (Nurix Therapeutics )?
Which analyst is the currently most bullish on NRIX (Nurix Therapeutics )?
Which analyst is the currently most reserved on NRIX (Nurix Therapeutics )?